Skip to main navigation menu Skip to main content Skip to site footer

Vol. 12 No. 10 (2025)
International Multidisciplinary Journal for Research & Development

Articles

MICROORGANISMS AND ONCOLOGY: THE ROLE OF BACTERIA IN CANCER DEVELOPMENT AND TREATMENT

Published 2025-10-17

  • Muhammadova Mumina Boxodirovna

Muhammadova Mumina Boxodirovna
Andijan Branch of Kokand University Faculty of Medicine

Abstract

This paper explores the complex relationship between microorganisms, particularly bacteria, and oncology. Recent research has highlighted the significant role that certain bacterial species play in both the development and progression of cancer. Some bacteria contribute to carcinogenesis through mechanisms such as chronic inflammation, production of carcinogenic metabolites, and modulation of the immune response. Conversely, beneficial bacteria can influence tumor suppression and enhance the effectiveness of cancer treatments. The emerging field of microbiome research has opened new avenues for understanding how microbial communities impact cancer risk, progression, and therapy response. Furthermore, bacterial-based therapies, including probiotics, antibiotics, and engineered bacteria, are being investigated as potential adjuncts in cancer treatment. This review summarizes current knowledge on the dual role of bacteria in oncology and emphasizes the importance of targeting the microbiome for improved cancer prevention and therapy strategies.

Keywords

microorganisms, bacteria, oncology, cancer development, carcinogenesis, microbiome, tumor progression, cancer treatment, bacterial therapy, immune modulation.

PDF

References

  1. Garrett, W.S. (2015). Cancer and the microbiota. Science, 348(6230), 80-86. https://doi.org/10.1126/science.aaa4972
  2. Zitvogel, L., Ma, Y., Raoult, D., Kroemer, G., & Gajewski, T.F. (2018). The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies. Science, 359(6382), 1366-1370. https://doi.org/10.1126/science.aar6918
  3. Schwabe, R.F., & Jobin, C. (2013). The microbiome and cancer. Nature Reviews Cancer, 13(11), 800-812. https://doi.org/10.1038/nrc3610
  4. Kostic, A.D., Chun, E., Robertson, L., Glickman, J.N., Gallini, C.A., Michaud, M., … & Garrett, W.S. (2013). Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host & Microbe, 14(2), 207-215. https://doi.org/10.1016/j.chom.2013.07.007
  5. Plottel, C.S., & Blaser, M.J. (2011). Microbiome and malignancy. Cell Host & Microbe, 10(4), 324-335. https://doi.org/10.1016/j.chom.2011.10.003
  6. Schwabe, R.F., & Jobin, C. (2013). The microbiome and cancer. Nature Reviews Cancer, 13(11), 800-812. https://doi.org/10.1038/nrc3610
  7. Kamarajah, S.K., Bundred, N.J., Xu, L., & Hanna, G.B. (2021). The role of the microbiome in cancer development and therapy: A review. Clinical and Translational Oncology, 23(5), 964-974. https://doi.org/10.1007/s12094-020-02525-2
  8. Gopalakrishnan, V., Spencer, C.N., Nezi, L., Reuben, A., Andrews, M.C., Karpinets, T.V., … & Wargo, J.A. (2018). Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients. Science, 359(6371), 97-103. https://doi.org/10.1126/science.aan4236
  9. Bullman, S., Pedamallu, C.S., Sicinska, E., Clancy, T.E., Zhang, X., Cai, D., … & Meyerson, M. (2017). Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer. Science, 358(6369), 1443-1448. https://doi.org/10.1126/science.aal5240
  10. Wong, S.H., & Yu, J. (2019). Gut microbiota in colorectal cancer: mechanisms of action and clinical applications. Nature Reviews Gastroenterology & Hepatology, 16(11), 690-704. https://doi.org/10.1038/s41575-019-0173-7
  11. Zitvogel, L., Daillère, R., Roberti, M.P., Routy, B., & Kroemer, G. (2017). Anticancer effects of the microbiome and its products. Nature Reviews Microbiology, 15(8), 465-478. https://doi.org/10.1038/nrmicro.2017.44
  12. Baxter, N.T., Zackular, J.P., Chen, G.Y., & Schloss, P.D. (2014). Structure of the gut microbiome following colonization with human feces determines colonic tumor burden. Microbiome, 2, 20. https://doi.org/10.1186/2049-2618-2-20
  13. Zitvogel, L., Kroemer, G., & Ma, Y. (2018). The microbiome and anticancer immunosurveillance. Cell, 172(1-2), 130-142. https://doi.org/10.1016/j.cell.2017.12.004
  14. Alexander, J.L., Wilson, I.D., Teare, J., Marchesi, J.R., Nicholson, J.K., & Kinross, J.M. (2017). Gut microbiota modulation of chemotherapy efficacy and toxicity. Nature Reviews Gastroenterology & Hepatology, 14(6), 356-365. https://doi.org/10.1038/nrgastro.2017.32
  15. Zitvogel, L., Ma, Y., & Kroemer, G. (2019). Microbiome and anticancer immunosurveillance. Cancer Discovery, 9(9), 1271-1285. https://doi.org/10.1158/2159-8290.CD-19-0600

Downloads

Download data is not yet available.